Molecular basis for sunitinib efficacy and future clinical development
Harvard University · Dana-Farber Cancer Institute · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
711
total citations
- FWCI
- 36.83
- Percentile
- 100%
- References
- 67
Citations per year
Authors
4Topics & keywords
Topics
Keywords
- Sunitinib
- Sunitinib malate
- Tyrosine-kinase inhibitor
- Medicine
- Imatinib
- Renal cell carcinoma
- Tyrosine kinase
- Stromal cell
UN Sustainable Development Goals
- Zero hunger
No related works found for this paper.